Conmed (CNMD) Tops Q4 EPS by 13c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.74 +0.32%
Financial Fact:
Income before income taxes: 9.99M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Income before income taxes: 9.99M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.34, $0.13 better than the analyst estimate of $1.21. Revenue for the quarter came in at $345.9 million versus the consensus estimate of $341 million.
GUIDANCE:
Conmed sees FY2025 EPS of $4.25-$4.40, versus the consensus of $4.03. Conmed sees FY2025 revenue of $1.34-1.37 billion, versus the consensus of $1.3 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arch Capital (ACGL) PT Raised to $106 at Keefe, Bruyette & Woods
- Sportradar Group AG (SRAD) Reports In-Line Q3 EPS ; Offers Guidance
- Versant Corp. (VSNT) Reports Q3 EPS of $0.34 ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
